[go: up one dir, main page]

WO2007110884A3 - Procede de preparation de chlorhydrate de fexofenadine anhydre tres pur - Google Patents

Procede de preparation de chlorhydrate de fexofenadine anhydre tres pur Download PDF

Info

Publication number
WO2007110884A3
WO2007110884A3 PCT/IN2007/000127 IN2007000127W WO2007110884A3 WO 2007110884 A3 WO2007110884 A3 WO 2007110884A3 IN 2007000127 W IN2007000127 W IN 2007000127W WO 2007110884 A3 WO2007110884 A3 WO 2007110884A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
highly pure
fexofenadine hydrochloride
pure anhydrous
anhydrous fexofenadine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2007/000127
Other languages
English (en)
Other versions
WO2007110884A2 (fr
Inventor
Lilit Wadhwa
Satyendra Pal Singh
Gajendra Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ind Swift Laboratories Ltd
Original Assignee
Ind Swift Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Swift Laboratories Ltd filed Critical Ind Swift Laboratories Ltd
Publication of WO2007110884A2 publication Critical patent/WO2007110884A2/fr
Anticipated expiration legal-status Critical
Publication of WO2007110884A3 publication Critical patent/WO2007110884A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un procédé innovant et industriellement avantageux permettant de préparer du chlorhydrate de fexofénadine très pur directement à partir de fexofénadine base sans isoler le chlorhydrate de fexofénadine hydraté.
PCT/IN2007/000127 2006-03-29 2007-03-28 Procede de preparation de chlorhydrate de fexofenadine anhydre tres pur Ceased WO2007110884A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN873DE2006 2006-03-29
IN873/DEL/2006 2006-03-29

Publications (2)

Publication Number Publication Date
WO2007110884A2 WO2007110884A2 (fr) 2007-10-04
WO2007110884A3 true WO2007110884A3 (fr) 2009-05-28

Family

ID=38541539

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000127 Ceased WO2007110884A2 (fr) 2006-03-29 2007-03-28 Procede de preparation de chlorhydrate de fexofenadine anhydre tres pur

Country Status (1)

Country Link
WO (1) WO2007110884A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012087100A (ja) * 2010-10-21 2012-05-10 Sumitomo Chemical Co Ltd 形態ｉのフェキソフェナジン一塩酸塩の製造方法
CN104072402B (zh) * 2014-07-16 2016-08-17 昆山龙灯瑞迪制药有限公司 一种新结晶形式的盐酸非索非那定化合物及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066429A1 (fr) * 2001-02-23 2002-08-29 Cilag Ag Procede de production d'hydrochlorure fexofenadine non hydrate et nouvelle forme cristalline ainsi obtenue
US20040004038A1 (en) * 2002-07-03 2004-01-08 Jfe Engineering Corporation Method and apparatus for treating sludge, and method and apparatus for treating wastewater utilizing the same
WO2005009175A2 (fr) * 2003-05-29 2005-02-03 Star Cushion Products, Inc. Procedes de fabrication de coussins cellulaires

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066429A1 (fr) * 2001-02-23 2002-08-29 Cilag Ag Procede de production d'hydrochlorure fexofenadine non hydrate et nouvelle forme cristalline ainsi obtenue
US20040004038A1 (en) * 2002-07-03 2004-01-08 Jfe Engineering Corporation Method and apparatus for treating sludge, and method and apparatus for treating wastewater utilizing the same
WO2005009175A2 (fr) * 2003-05-29 2005-02-03 Star Cushion Products, Inc. Procedes de fabrication de coussins cellulaires

Also Published As

Publication number Publication date
WO2007110884A2 (fr) 2007-10-04

Similar Documents

Publication Publication Date Title
EP2460797A3 (fr) Procédé de préparation d'ivabradine hydrochloride
IL190551A0 (en) Novel process for the preparation of acid chlorides
TW200833657A (en) Novel process
WO2009139817A3 (fr) Produit pharmaceutique cristallin et ses procédés de préparation et d'utilisation
WO2011015522A3 (fr) Procédé de fabrication de composés pharmaceutiquement actifs
WO2010062590A3 (fr) Procédé de fabrication de dérivés de l-alanine protégée
MY147732A (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
WO2006099468A3 (fr) Procede de purification de la duloxetine hydrochloride
WO2010060624A3 (fr) Traitement à sec et nouvelles formes de lacosamide
EP1613573A4 (fr) Production de 5-methyl-1-hydrocarbyl-2-pyrrolidone par amination reductrice d'acide levulinique
MX2011007978A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
WO2004014310A3 (fr) Nouveaux procedes de preparation de composes antagonistes opioides peripheriques et de leurs intermediaires
ZA200900282B (en) An improved process for the preparation of sucralose of high purity
WO2010004578A3 (fr) Nouveaux procédés améliorés de préparation de la palipéridone
HUP0501167A3 (en) Process for industrial scale production of high purity donepezil hydrochloride polymorph i.
WO2010121877A3 (fr) Procédé de préparation de l'olopatadine
WO2010083996A8 (fr) Procédé de synthèse de la mémantine
MX2012002818A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
EP1765761A4 (fr) Nouveaux analogues de 3-o-acetyl-11-ceto-beta-acide boswellique
WO2007099552A3 (fr) Nouvelle forme cristalline d'atorvastatine hémi-magnésium
IL188535A0 (en) Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride
WO2010119450A3 (fr) Procédé amélioré pour la préparation de la desmopressine ou de ses sels pharmaceutiquement acceptables
WO2007110884A3 (fr) Procede de preparation de chlorhydrate de fexofenadine anhydre tres pur
WO2009034582A3 (fr) Procédé pour la préparation de chlorhydrate de fexofénadine amorphe
WO2008099418A3 (fr) Procédé amélioré de préparation de chlohydrate de bupropion

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07736583

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07736583

Country of ref document: EP

Kind code of ref document: A2